Famotidine USP 20 mg — Class II drug recall D-1057-2017
Terminated recall by PD-Rx Pharmaceuticals, Inc., reported 2017-08-09, distributed nationwide. Failed Tablet/Capsule Specification: out of specification for tablet weight.
| Recall number | D-1057-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, United States |
| Recall initiated | 2017-07-28 |
| Classified | 2017-08-03 |
| Reported by FDA | 2017-08-09 |
| Terminated | 2017-12-06 |
| Distributed | Nationwide (US) |
| Quantity | 100 bottles |
| Reason classes | specification failure |
| NDC | 55289-0765-30 |
| Lot numbers | A17F55 |
| Expiration dates | 2018-06-30 |
Product
Famotidine USP 20 mg, 30 tablets bottle, Rx, PKG By; PD Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 --- NDC 55289-765-30
Reason for recall
Failed Tablet/Capsule Specification: out of specification for tablet weight.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1057-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.